The mitochondrial protease YME1L regulates type 1 interferon signaling via the cgas-sting pathway in AML

Y Yihe Zhang (Department of Molecular Biology, University of Texas Southwestern Medical Center) G Geethu Thomas R Rose Hurren (Princess Margaret Cancer Centre, University Health Network) Y Yongran Yan (Princess Margaret Cancer Centre, University Health Network) D Dakai Ling M Marcela Gronda (Princess Margaret Cancer Centre, University Health Network) A Andrea Arruda (Princess Margaret Cancer Centre, University Health Network) M Mark Minden (1Princess Margaret Cancer Centre, Department of Medical Oncology and Hematology, Toronto, Canada) A Aaron Schimmer

Abstract

Abstract Yeast Mitochondrial Escape 1-Like 1 (YME1L) is an inner mitochondrial membrane–anchored ATP-dependent metalloprotease. Here, we investigated its expression and functional role in acute myeloid leukemia (AML). YME1L protein was upregulated in 6 out of 7 AML cell lines and 17 of 23 primary AML patient samples compared to normal hematopoietic stem cells. Analysis of the TCGA dataset revealed that high YME1L mRNA expression correlated with inferior 5-year overall survival in AML patients. To evaluate the essentiality of YME1L in AML, we knocked down the protease in AML cell lines (OCI-AML2, NB4, TEX, and THP-1) with shRNA. YME1L knockdown decreased cell proliferation and clonogenic growth in all tested cell lines. Moreover, YME1L depletion decreased the engraftment of TEX cells into the marrow of immune deficient mice. Interestingly, YME1L knockdown did not induce cell death as measured by Annexin V/PI staining. Rather, YME1L knockdown induced AML differentiation as evidenced by upregulation of CD14, a marker of monocytic differentiation. To understand how YME1L promoted differentiation and decreased proliferation, we performed RNA sequencing of AML cells after YME1L depletion. Knockdown of YME1L upregulated genes associated with type I interferon (IFN) signaling and viral mimicry pathways. By qPCR, we confirmed upregulation of IFN-β, IFN-γ, and interferon-stimulated genes, ISG15, IFI44, IFIT2 after YME1L knockdown. We demonstrated that activation of the IFN signaling was secondary to activation of the cGAS–STING pathway as pharmacologically inhibiting STING abolished the upregulation of IFN signaling after YME1L depletion. We also showed that YME1L knockdown promoted the release of mitochondrial double-stranded DNA into the cytoplasm, a known trigger of IFN signaling. Finally, we demonstrated that inhibiting the VDAC channel with VBIT-4 blocked the upregulation of IFN signaling after YME1L knockdown, thus supporting the functional importance of mtDNA efflux into the cytoplasm as the mechanism explaining increased IFN signaling after YME1L depletion. In summary, we demonstrated that YME1L is overexpressed in a subset of AML samples and is required for AML proliferation and clonogenic growth. YME1L regulates the leakage of mtDNA into the cytoplasm, activation of the cGAS–STING–IFN axis, and AML differentiation. Thus, we have uncovered novel functions for the mitochondrial protease YME1L in AML and new mechanisms for how a mitochondrial protease regulates nuclear gene expression and progenitor function.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 6765-6765
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (9)

Y

Yihe Zhang

Department of Molecular Biology, University of Texas Southwestern Medical Center

G

Geethu Thomas

R

Rose Hurren

Princess Margaret Cancer Centre, University Health Network

Y

Yongran Yan

Princess Margaret Cancer Centre, University Health Network

D

Dakai Ling

M

Marcela Gronda

Princess Margaret Cancer Centre, University Health Network

A

Andrea Arruda

Princess Margaret Cancer Centre, University Health Network

M

Mark Minden

1Princess Margaret Cancer Centre, Department of Medical Oncology and Hematology, Toronto, Canada

A

Aaron Schimmer